Ms. Marina Blūma (née Selivanova) received a Diploma with a major in Clinical Psychology at the St. Petersburg State University, Russia (2011), and a Master’s Degree in Interdisciplinary Neuroscience (2015) at the Goethe University in Frankfurt am Main, Germany. After this, she worked as a Research Associate at the Giessen University, Germany at the Department of Child and Adolescent Clinical Psychology (2015-2016). In 2017-2020 she held a position of a Marie-Curie Early Stage researcher within the ITN-ETN “Blood Biomarker-based Diagnostic Tools for Early-stage Alzheimer’s Disease” (BBDiag) consortium at the Sapienza University of Rome. Her research interests are preclinical neuroimaging biomarkers in humans and animal models of Alzheimer’s Disease, and the disease heterogeneity.